My watch list
my.bionity.com  
Login  

Registration Manager (m/f) – Part-time 50%

Advertisement No. 206761BR
More about Sandoz
  • Job Offers

    Lab Head Analytical Development (m/f)

    Come and work with us as Lab Head Analytical Development (m/f) Area of Responsibility Leading an analytical team of 5 to 10 associates: resource planning, Instrument qualification, experimentation and method development, data handling and data management for the analysis and development o ... more

    Scientist Drug Product Analytical Development (m/f)

    Come and work with us as Scientist Drug Product Analytical Development (m/f) Areas of Responsibility Support developmental projects as protein analytical expert Compile analytical reports and regulatory documents Act as partner for Drug Product Development (i.e. liquid or lyo in syringe o ... more

    Galenical Expert (m/f)

    Come and work with us as Galenical Expert (m/f) Areas of Responsibility Plan, perform and evaluate experiments for establishing of compositions, robust and state-of-the-art manufacturing procedures and packaging via deformulation/ formulation experiments Compilation of technical documents ... more

  • News

    Sandoz initiates two more Phase III biosimilar trials

    Sandoz announced that it has initiated two milestone Phase III clinical trials - one for biosimilar filgrastim (Amgen's Neupogen®) in the US market, the other for its global pegfilgrastim development program (Amgen's Neulasta®).The filgrastim study is to evaluate the efficacy and safety of ... more

    Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab

    Sandoz announced that it has begun a phase II clinical trial in patients for biosimilar rituximab (Roche's Rituxan® / Mabthera®), a monoclonal antibody indicated in conditions including non-Hodgkin's lymphoma and rheumatoid arthritis.The phase II study in patients suffering from rheumatoid ... more

    Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox

    Sandoz announced the introduction of enoxaparin sodium injection, the first generic version of Lovenox®, in the US. Product shipment began immediately following approval by the US Food and Drug Administration (FDA). According to IMS data enoxaparin sodium injection is the best-selling hosp ... more

  • Companies

    Sandoz Biopharmaceuticals and Oncology Injectables

    As an internationally significant company, we are a leader in the Austrian pharmaceutical industry. Together with our partners we are committed to health, offering * cutting-edge specialty pharmaceuticals in the areas neurology, oncology and immunology * production of highly effec ... more

    Sandoz GmbH

    Sandoz is a fully integrated partner in development and cGMP production of recombinant peptides and proteins. In the field of microbial fermentation, Sandoz offers production capacity at 1,300L, 3,000L, 13,000L and 40,000L scale. The flexibility of production capabilities and fully integr ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE